Prozac proves no better than a placebo in treating kids with autism
Drugs called SSRIs didn’t ease obsessive-compulsive symptoms in children with the disorder
A randomized clinical trial found that the antidepressant marketed as Prozac is no more effective than a placebo at treating obsessive-compulsive symptoms in kids and teens with autism.
BSIP SA/Alamy Stock Photo
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
